An extract of feverfew inhibits interactions of human platelets with collagen substrates
- 1 December 1987
- journal article
- Published by Elsevier BV in Thrombosis Research
- Vol. 48 (5), 511-518
- https://doi.org/10.1016/0049-3848(87)90383-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groupsJournal of Pharmacy and Pharmacology, 1987
- Alteration of platelet function by diamide corresponds to changes in phospholipid content of platelet cytoskeletonsThrombosis Research, 1987
- Compounds extracted from feverfew that have anti-secretory activity contain an α-methylene butyrolactone unitJournal of Pharmacy and Pharmacology, 1986
- Efficacy of feverfew as prophylactic treatment of migraine.BMJ, 1985
- EXTRACTS OF FEVERFEW INHIBIT GRANULE SECRETION IN BLOOD PLATELETS AND POLYMORPHONUCLEAR LEUCOCYTESThe Lancet, 1985
- Chemical modification of cytoskeletal proteins of human blood platelets by diamideThrombosis Research, 1984
- Antianginal drug trapidil (RocornalR ) inhibits spreading of platelets and formation of surface-bound thrombi-like aggregatesThrombosis Research, 1983
- Time-response changes in the thrombogenicity of platelets spread on a collagen-coated surfaceThrombosis Research, 1980
- The effect of acetylsalicylic acid and indomethacin on rabbit platelet adherence to collagen and the subendothelium in the presence of a low or high hematocritThrombosis Research, 1978
- Diamide, a new reagent for the intracellular oxidation of glutathione to the disulfideBiochemical and Biophysical Research Communications, 1969